logo

For the Inventor, By the Inventor

Ecublens, Switzerland

Sophie Lohmann

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Ac Immune Sa. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sophie Lohmann. Retrieved from https://idiyas.com/inventor/sophie-lohmann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal1 out of 69 
 
Ac Immune Sa
 patents

Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents
1. 8673940 - Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins (2014-03-18),

Title: Sophie Lohmann: Innovator in Amyloid-Related Treatments

Introduction

Sophie Lohmann is a prominent inventor based in Ecublens, Switzerland. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diseases associated with amyloid proteins. Her innovative work has the potential to impact the lives of many individuals suffering from serious health conditions.

Latest Patents

Sophie Lohmann holds 1 patent for her invention titled "Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins." This patent relates to novel compounds that can be employed in treating disorders associated with amyloid proteins, such as Alzheimer's disease. The compounds are also applicable in treating ocular diseases linked to abnormalities in the visual system. Furthermore, her invention includes pharmaceutical compositions comprising these compounds and methods for preparing medicaments aimed at treating or preventing diseases associated with amyloid proteins.

Career Highlights

Sophie Lohmann is associated with Ac Immune SA, a company dedicated to developing innovative therapies for neurodegenerative diseases. Her work at Ac Immune has positioned her as a key player in the pharmaceutical industry, focusing on groundbreaking research and development.

Collaborations

Sophie has collaborated with notable professionals in her field, including Wolfgang Froestl and Nampally Sreenivasachary. These collaborations have enhanced her research efforts and contributed to the advancement of treatments for amyloid-related diseases.

Conclusion

Sophie Lohmann's contributions to the field of pharmaceuticals, particularly in the treatment of amyloid-related conditions, highlight her innovative spirit and dedication to improving healthcare. Her work continues to pave the way for new therapeutic options that could benefit countless individuals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…